About
RoLink Biotechnology is a Hungarian startup founded by two young medical doctors of the National Laboratory of Virology transforming pandemic preparedness with a proprietary UV-inactivation technology that renders viruses non-infectious while preserving 100% of their structure. This enables safer, faster, and more cost-effective R&D, diagnostics, and vaccine development—cutting OPEX by up to 90%. Operating in the same team and partnership with Central Europe’s only university-based BSL-4 lab, RoLink combines startup agility with top-tier infrastructure. Integrated into EDF rapid response programs, RoLink is led by founders Dr. Roland Hetényi and Dr. Dániel Hanna (former medical school classmates) experts in virology, and vaccine development, and purification, successful history of clinical study, backed by an ex-BCG consultant, an IP expert, and national biodefense experts.
Area of activity
ResearchR&D&I